Tag Archive for: NMPA

China Continues to Implement UDI of Medical Devices with Third Batch Release

/in , /by

The NMPA Continues UDI Implementation in China with Third Batch Release announced February 17, 2023 including 103 types of Class II medical devices.

Read more

China NMPA Updates Compulsory Standards for Medical Devices

/in , /by

On November 18th, 2022, the China NMPA released updated medical device compulsory standards covering a wide variety of medical devices, a list of which can be found on the National Institute for Food and Drug Control. While the NMPA often releases new standards for medical devices, the recent update is particularly comprehensive, with nearly every kind of device affected in the next year.

Read more

China NMPA Updates Classification of Sodium Hyaluronate Products

/in , /by

On November 10th, 2022, the China NMPA issued a notice regarding the classification of medical sodium hyaluronate products.

Read more

China’s NMPA Publishes Classification Catalogue Adjustments for Comment

/in , /by

On October 31st, 2022, China’s NMPA published a Classification Catalogue adjustment for public comment.

Read more

China’s NMPA Begins Issuing Registration Certificates Electronically

/in , /by

On October 26, 2022, the NMPA issued a notice to begin implementing electronic registration certificates for certain approved medical devices.

Read more

CHINA TAKES STEPS TO ENSURE QUALITY OF COVID-19 RELATED EXPORTS

/in , /by

Chinese officials are taking steps to reduce fraudulent exports. Only products with NMPA registration can be exported to ensure standards and quality during COVID-19 crisis.

Read more

CHINA CHANGES CLINICAL DATA REQUIREMENTS FOR MEDICAL DEVICE REGISTRATION

/in , /by

The changes to clinical data requirements will significantly decrease the regulatory burden for many medical device manufacturers seeking to access the Chinese market by eliminating the time and expense of conducting a local clinical trial.

Read more

CHINA WARNS MANUFACTURERS ABOUT RISK ASSESSMENT REPORT DEADLINE

/in , /by

Asia Actual works with highly experienced professionals in China that can provide you with accurate and timely Risk Assessment reports for your products that will not only satisfy the NMPA’s requirements but could also be used for updating Clinical Evaluation Reports in other markets.

Read more

HONG KONG EXTENDS PILOT PROGRAM TO RECOGNIZE CHINA AND KOREA AS REFERENCE COUNTRIES

/in , /by

By allowing manufacturers to show conformity to the MDD’s assessment requirements by using NMPA or MFDS approvals, Chinese and Korean manufacturers would save 6-9 months during the application process.

Read more

Submission Changes in China: ToCs and the eRPS

/in , /by

Manufacturers interested in registering a medical device in China can now submit electronic documents online through the new eRPS system.

Read more